Abstract
ObjectivesUptake of influenza, pneumococcal and shingles vaccines in older adults vary across regions and socioeconomic backgrounds. In this study, we study the coverage and factors associated with vaccination uptake, as well as refusal in the unvaccinated population and their associations with ethnicity, deprivation, household size and health conditions.Design, setting and participantsThis is a cross-sectional study of adults aged 65 years or older in England, using a large primary care database. Associations of vaccine uptake and refusal in the unvaccinated with ethnicity, deprivation, household size and health conditions were modelled using multivariable logistic regression.Outcome measureInfluenza, pneumococcal and shingles vaccine uptake and refusal (in the unvaccinated).ResultsThis study included 2 054 463 patients from 1318 general practices. 1 711 465 (83.3%) received at least one influenza vaccine, 1 391 228 (67.7%) pneumococcal vaccine and 690 783 (53.4%) shingles vaccine. Compared with White ethnicity, influenza vaccine uptake was lower in Chinese (OR 0.49; 95% CI 0.45 to 0.53), ‘Other ethnic’ groups (0.63; 95% CI 0.60 to 0.65), black Caribbean (0.68; 95% CI 0.64 to 0.71) and black African (0.72; 95% CI 0.68 to 0.77). There was generally lower vaccination uptake among more deprived individuals, people living in larger household sizes (three or more persons) and those with fewer health conditions. Among those who were unvaccinated, higher odds of refusal were associated with the black Caribbean ethnic group and marginally with increased deprivation, but not associated with higher refusal in those living in large households or those with lesser health conditions.ConclusionCertain ethnic minority groups, deprived populations, large households and 'healthier' individuals were less likely to receive a vaccine, although higher refusal was only associated with ethnicity and deprivation but not larger households nor healthier individuals. Understanding these may inform tailored public health messaging to different communities for equitable implementation of vaccination programmes.
Funder
Cancer Research UK
NIHR Leicester Biomedical Research Centre
UK Research and Innovation
Oxford Wellcome Institutional Strategic Support Fund
MRC Epidemiology Unit
NHS
NIHR
John Fell Oxford University Press Research Fund
NIHR Applied Research Collaboration East Midlands
NHS East of England
Reference30 articles.
1. SARS-cov-2, COVID-19 and the ageing immune system;Bartleson;Nat Aging,2021
2. Public Health England . Pneumococcal polysaccharide vaccine (PPV) coverage report, england, april 2019 to march 2020. n.d. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/899458/hpr1320_ppv-vc.pdf
3. Public Health England . Seasonal influenza vaccine uptake in GP patients: winter season 2020 to 2021. n.d. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/996033/Annual-Report_SeasonalFlu-Vaccine_GPs_2020_to_2021.pdf
4. England PH . Shingles coverage report (adults eligible from april to september 2020 andvaccinated to end of december 2020): englandquarter 2 report of financial year 2020 to 2021. n.d. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/955523/SP_hpr0321_SHNGLS-vc_Q2-final-3_refs.pdf
5. Europe W . Evaluation of seasonal influenza vaccination policies and coverage in the WHO european region. n.d. Available: https://www.euro.who.int/__data/assets/pdf_file/0003/241644/Evaluation-of-seasonal-influenza-vaccination-policies-and-coverage-in-the-WHO-European-Region.pdf